{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T22:09:23Z","timestamp":1770761363671,"version":"3.50.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11926-025-01191-y","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:38:47Z","timestamp":1748525927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Family Planning and Rheumatoid Arthritis"],"prefix":"10.1007","volume":"27","author":[{"given":"Catherine","family":"Sims","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehret Birru","family":"Talabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.rdc.2007.01.001","volume":"33","author":"A Golding","year":"2007","unstructured":"Golding A, Haque U, Giles J. Rheumatoid arthritis and reproduction. Rheum Dis Clin North Am. 2007;33:319\u201343.","journal-title":"Rheum Dis Clin North Am"},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.semarthrit.2019.09.010","volume":"49","author":"H Smeele","year":"2019","unstructured":"Smeele H, Dolhain R. Current perspectives on fertility, pregnancy and childbirth in patients with Rheumatoid Arthritis. Semin Arthritis Rheum. 2019;49:S32\u20135.","journal-title":"Semin Arthritis Rheum"},{"key":"1191_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.rdc.2016.12.004","volume":"43","author":"P de Jong","year":"2017","unstructured":"de Jong P, Dolhain R. Fertility, Pregnancy, and Lactation in Rheumatoid Arthritis. Rheum Dis Clin North Am. 2017;43:227\u201337.","journal-title":"Rheum Dis Clin North Am"},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acr.21593","volume":"64","author":"M Clowse","year":"2012","unstructured":"Clowse M, Chakravarty E, Costenbader K, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012;64:668\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0044-1790255","volume":"42","author":"D Marcy","year":"2024","unstructured":"Marcy D, Zell J, Demoruelle M. Rheumatoid Arthritis and Pregnancy: Managing Disease Activity and Fertility Concerns. Semin Reprod Med. 2024;42:169\u201377.","journal-title":"Semin Reprod Med"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.semarthrit.2020.07.003","volume":"50","author":"D De Cock","year":"2020","unstructured":"De Cock D, Brants L, Soenen I, Pazmino S, Bertrand D, Stouten V, et al. A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis. Semin Arthritis Rheum. 2020;50:873\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.3390\/ijerph19053088","volume":"19","author":"W Ta\u0144ski","year":"2022","unstructured":"Ta\u0144ski W, Dudek K, Tomasiewicz A, \u015awi\u0105toniowska-Lonc N. Sexual Dysfunction and Quality of Life in Patients with Rheumatoid Arthritis. Int J Environ Res Public Health. 2022;19:3088.","journal-title":"Int J Environ Res Public Health"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"e003762","DOI":"10.1136\/rmdopen-2023-003762","volume":"10","author":"L Pina Vegas","year":"2024","unstructured":"Pina Vegas L, Drouin J, Weill A, Dray-Spira R. Pregnancy outcomes in women with rheumatoid arthritis: an 11-year French nationwide study. RMD Open. 2024;10:e003762.","journal-title":"RMD Open"},{"key":"1191_CR9","doi-asserted-by":"publisher","unstructured":"Nakai T, Fukui S, Ozawa H, Kitada A, Okada M, Kishimoto M. Management of pregnant with rheumatoid arthritis: preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes. Best Pract Res Clin Rheumatol. 2025;39(1):102022. https:\/\/doi.org\/10.1016\/j.berh.2024.102022.","DOI":"10.1016\/j.berh.2024.102022"},{"issue":"2","key":"1191_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semarthrit.2019.03.011","volume":"49","author":"S Kishore","year":"2019","unstructured":"Kishore S, Mittal V, Majithia V. Obstetric outcomes in women with rheumatoid arthritis: Results from Nationwide Inpatient Sample Database 2003\u20132011. Semin Arthritis Rheum. 2019;49(2):236\u201340.","journal-title":"Semin Arthritis Rheum"},{"key":"1191_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10995-006-0073-3","volume":"10","author":"SD Reed","year":"2006","unstructured":"Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in Washington State. Matern Child Health J. 2006;10:361\u20136.","journal-title":"Matern Child Health J"},{"key":"1191_CR12","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1093\/rheumatology\/keab894","volume":"61","author":"K Hellgren","year":"2022","unstructured":"Hellgren K, Secher AE, Glintborg B, Rom AL, Gudbjornsson B, Michelsen B, et al. Pregnancy outcomes in relation to disease activity and anti-rheumatic treatment strategies in women with rheumatoid arthritis: a matched cohort study from Sweden and Denmark. Rheumatology (Oxford). 2022;61:3711\u201322.","journal-title":"Rheumatology (Oxford)"},{"key":"1191_CR13","doi-asserted-by":"publisher","first-page":"e002445","DOI":"10.1136\/rmdopen-2022-002445","volume":"8","author":"AEP Secher","year":"2022","unstructured":"Secher AEP, Granath F, Glintborg B, Rom A, Hetland ML, Hellgren K. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark. RMD Open. 2022;8:e002445.","journal-title":"RMD Open"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"e059203","DOI":"10.1136\/bmjopen-2021-059203","volume":"12","author":"YC Tsai","year":"2022","unstructured":"Tsai YC, Chang HC, Chiou MJ, Luo SF, Kuo CF. Fetal-neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study. BMJ Open. 2022;12:e059203.","journal-title":"BMJ Open"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/eurheartj\/ehae108","volume":"45","author":"S Zahid","year":"2024","unstructured":"Zahid S, Mohamed MS, Rajendran A, Minhas AS, Khan MZ, Nazir NT, et al. Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis. Eur Heart J. 2024;45:1524\u201336.","journal-title":"Eur Heart J"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41584-019-0351-2","volume":"16","author":"F F\u00f6rger","year":"2020","unstructured":"F\u00f6rger F, Villiger PM. Immunological adaptations in pregnancy that modulate rheumatoid arthritis disease activity. Nat Rev Rheumatol. 2020;16:113\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3899\/jrheum.180226","volume":"46","author":"H Jethwa","year":"2019","unstructured":"Jethwa H, Lam S, Smith C, Giles I. Does Rheumatoid Arthritis Really Improve During Pregnancy? A Systematic Review and Metaanalysis. J Rheumatol. 2019;46:245\u201350.","journal-title":"J Rheumatol"},{"key":"1191_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/14397595.2020.1829342","volume":"31","author":"E Nakamura","year":"2021","unstructured":"Nakamura E, Kotani T, Hiramatsu Y, Hata K, Yoshikawa A, Matsumura Y, et al. Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis. Mod Rheumatol. 2021;31:809\u201316.","journal-title":"Mod Rheumatol"},{"key":"1191_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2020-219547","volume":"80","author":"HT Smeele","year":"2021","unstructured":"Smeele HT, R\u00f6der E, Wintjes HM, Kranenburg-van Koppen LJ, Hazes JM, Dolhain RJ. Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study. Ann Rheum Dis. 2021;80:859\u201364.","journal-title":"Ann Rheum Dis"},{"key":"1191_CR20","doi-asserted-by":"publisher","first-page":"887462","DOI":"10.3389\/fphar.2022.887462","volume":"13","author":"MC Gerardi","year":"2022","unstructured":"Gerardi MC, Crisafulli F, Garc\u00eda-Fernandez A, Lini D, Bazzani C, Cavazzana I, et al. Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis. Front Pharmacol. 2022;13:887462.","journal-title":"Front Pharmacol"},{"key":"1191_CR21","doi-asserted-by":"publisher","first-page":"A502","DOI":"10.1016\/j.autrev.2011.12.003","volume":"11","author":"GC Hughes","year":"2012","unstructured":"Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11:A502\u201314.","journal-title":"Autoimmun Rev"},{"key":"1191_CR22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3899\/jrheum.201128","volume":"48","author":"A Pathi","year":"2021","unstructured":"Pathi A, Wright M, Smed MK, Nelson JL, Olsen J, Hetland ML, et al. The Rheumatoid Arthritis Gene Expression Signature Among Women Who Improve or Worsen During Pregnancy: A Pilot Study. J Rheumatol. 2021;48:985\u201391.","journal-title":"J Rheumatol"},{"key":"1191_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.41191","volume":"72","author":"LR Sammaritano","year":"2020","unstructured":"Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2020;72:529\u201356.","journal-title":"Arthritis Rheumatol"},{"key":"1191_CR24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/acr2.1016","volume":"1","author":"M Birru Talabi","year":"2019","unstructured":"Birru Talabi M, Eudy AM, Jayasundara M, Haroun T, Nowell WB, Curtis JR, et al. Pregnancy, Periods, and \u201cThe Pill\u201d: Exploring the Reproductive Experiences of Women with Inflammatory Arthritis. ACR Open Rheumatol. 2019;1:125\u201332.","journal-title":"ACR Open Rheumatol"},{"key":"1191_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/acr.24249","volume":"73","author":"T Wolgemuth","year":"2021","unstructured":"Wolgemuth T, Stransky OM, Chodoff A, Kazmerski TM, Clowse MEB, Birru TM. Exploring the Preferences of Women Regarding Sexual and Reproductive Health Care in the Context of Rheumatology: A Qualitative Study. Arthritis Care Res (Hoboken). 2021;73:1194\u2013200.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.rdc.2022.02.009","volume":"48","author":"A Castro-Gutierrez","year":"2022","unstructured":"Castro-Gutierrez A, Young K, Bermas BL. Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome. Rheum Dis Clin North Am. 2022;48:523\u201335.","journal-title":"Rheum Dis Clin North Am"},{"issue":"25","key":"1191_CR27","first-page":"00818","volume":"S0003\u20134967","author":"L R\u00fcegg","year":"2025","unstructured":"R\u00fcegg L, Pluma A, Hamroun S, Cecchi I, Perez-Garcia LF, Anderson PO, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis. 2025;S0003\u20134967(25):00818.","journal-title":"Ann Rheum Dis"},{"key":"1191_CR28","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62:e48\u201388.","journal-title":"Rheumatology (Oxford)"},{"key":"1191_CR29","unstructured":"Mother to Baby. https:\/\/mothertobaby.org. Accessed 13 Apr 2025"},{"key":"1191_CR30","unstructured":"American College of Rheumatology. Reproductive Health Initiative. https:\/\/rheumatology.org\/reproductive-health-initiative. Accessed\u00a030 Jan 2025"},{"key":"1191_CR31","unstructured":"U.S. Food and Drug Administration. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication, Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later. October 2020. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/nonsteroidal-anti-inflammatory-drugs-nsaids-drug-safety-communication-avoid-use-nsaids-pregnancy-20#:~:text=FDA%20recommends%20that%20health%20care,dose%20and%20shortest%20duration%20possible. Accessed\u00a019 Feb 2025"},{"key":"1191_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14740338.2022.2020246","volume":"21","author":"CT Castro","year":"2022","unstructured":"Castro CT, Gama RS, Pereira M, Oliveira MG, Dal-Pizzol TS, Barreto ML, et al. Effect of Acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis. Expert Opin Drug Saf. 2022;21:241\u201351.","journal-title":"Expert Opin Drug Saf"},{"key":"1191_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rdc.2017.04.013","volume":"43","author":"G Bandoli","year":"2017","unstructured":"Bandoli G, Palmsten K, Forbess Smith CJ, Chambers CD. A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes. Rheum Dis Clin North Am. 2017;43:489\u2013502.","journal-title":"Rheum Dis Clin North Am"},{"key":"1191_CR34","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/rheumatology\/kez405","volume":"59","author":"K Palmsten","year":"2020","unstructured":"Palmsten K, Bandoli G, Vazquez-Benitez G, Xi M, Johnson DL, Xu R, Chambers CD. Oral corticosteroid use during pregnancy and risk of preterm birth. Rheumatology (Oxford). 2020;59:1262\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"1191_CR35","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1007\/s10067-022-06233-9","volume":"41","author":"L Luo","year":"2022","unstructured":"Luo L, Li X, Yan R, Zhang H, Li C. Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring. Clin Rheumatol. 2022;41:3135\u201341.","journal-title":"Clin Rheumatol"},{"key":"1191_CR36","doi-asserted-by":"publisher","first-page":"e001036","DOI":"10.1136\/lupus-2023-001036","volume":"11","author":"S Balevic","year":"2024","unstructured":"Balevic S, Sims CA, Eudy A, Smith V, Clowse M. Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease. Lupus Sci Med. 2024;11:e001036.","journal-title":"Lupus Sci Med"},{"issue":"7S Suppl 1","key":"1191_CR37","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/RHU.0000000000002123","volume":"30","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Safety of Medications Used to Treat Autoimmune Rheumatic Diseases During Pregnancy and Lactation. J Clin Rheumatol. 2024;30(7S Suppl 1):S25\u201333.","journal-title":"J Clin Rheumatol"},{"key":"1191_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3109\/03009748509100404","volume":"14","author":"KA Grindulis","year":"1985","unstructured":"Grindulis KA, McConkey B. Does sulphasalazine cause folate deficiency in rheumatoid arthritis? Scand J Rheumatol. 1985;14:265\u201370.","journal-title":"Scand J Rheumatol"},{"key":"1191_CR39","unstructured":"U.S. Food and Drug Administration. FDA Alerts Health Care Professionals of Pregnancy Problems Associated with Thiopurines. April 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-alerts-health-care-professionals-pregnancy-problems-associated-thiopurines. Accessed\u00a028 Feb 2025"},{"key":"1191_CR40","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s12884-022-05191-z","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Hu Y, Chen F, Shen M. Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis. BMC Pregnancy Childbirth. 2022;22:854.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1191_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/annrheumdis-2021-221036","volume":"81","author":"N Ghalandari","year":"2022","unstructured":"Ghalandari N, Kemper E, Crijns IH, Wolbink G, Rispens T, Smeele HT, et al. Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy. Ann Rheum Dis. 2022;81:402\u20135.","journal-title":"Ann Rheum Dis"},{"key":"1191_CR42","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","volume":"117","author":"EF Chakravarty","year":"2011","unstructured":"Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011;117:1499\u2013506.","journal-title":"Blood"},{"key":"1191_CR43","unstructured":"Drugs and Lactation Database (LactMed). National Center for Biotechnology Information. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK501922\/#IX-H. Accessed\u00a017 Jan 2025"},{"key":"1191_CR44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.38368","volume":"66","author":"C Weber-Schoendorfer","year":"2014","unstructured":"Weber-Schoendorfer C, Chambers C, Wacker E, Beghin D, Bernard N, Network of French Pharmacovigilance Centers, et al. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study. Arthritis Rheumatol. 2014;66:1101\u201310.","journal-title":"Arthritis Rheumatol"},{"key":"1191_CR45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/annrheumdis-2017-212078","volume":"77","author":"A B\u00e9rard","year":"2018","unstructured":"B\u00e9rard A, Zhao JP, Shui I, Colilla S. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes. Ann Rheum Dis. 2018;77:500\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1191_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.reprotox.2020.04.073","volume":"95","author":"LJ Henson","year":"2020","unstructured":"Henson LJ, Afsar S, Davenport L, Purvis A, Poole EM, Truffinet P. Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide. Reprod Toxicol. 2020;95:45\u201350.","journal-title":"Reprod Toxicol"},{"key":"1191_CR47","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/bdr2.2221","volume":"115","author":"R Alothman","year":"2023","unstructured":"Alothman R, Yeung J, Waterman E, Lepik C, Amiri N. Leflunomide exposure through second trimester of pregnancy: A case report. Birth Defects Res. 2023;115:1566\u20139.","journal-title":"Birth Defects Res"},{"key":"1191_CR48","first-page":"2224","volume":"41","author":"C Raine","year":"2023","unstructured":"Raine C, Ciurtin C, Jury EC, Williams DJ, Bennett D, Manson JJ, et al. DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritis. Clin Exp Rheumatol. 2023;41:2224\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"13","key":"1191_CR49","doi-asserted-by":"publisher","first-page":"867610","DOI":"10.3389\/fendo.2022.867610","volume":"17","author":"H Huang","year":"2022","unstructured":"Huang H, Wang Y, Xie W, Geng Y, Gao D, Zhang Z. Impact of Treat-to-Target Therapy on Bone Mineral Density Loss in Patients With Rheumatoid Arthritis: A Prospective Cohort Study. Front Endocrinol (Lausanne). 2022;17(13):867610.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1191_CR50","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/GCO.0000000000000641","volume":"32","author":"FR P\u00e9rez-L\u00f3pez","year":"2020","unstructured":"P\u00e9rez-L\u00f3pez FR, Pilz S, Chedraui P. Vitamin D supplementation during pregnancy: an overview. Curr Opin Obstet Gynecol. 2020;32:316\u201321.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1191_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12916-023-02837-3","volume":"21","author":"M Luan","year":"2023","unstructured":"Luan M, Yang F, Miao M, Yuan W, Gissler M, Arkema EV, et al. Rheumatoid arthritis and the risk of postpartum psychiatric disorders: a Nordic population-based cohort study. BMC Med. 2023;21:126.","journal-title":"BMC Med"},{"key":"1191_CR52","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3899\/jrheum.2023-0105","volume":"50","author":"D Shridharmurthy","year":"2023","unstructured":"Shridharmurthy D, Lapane KL, Nunes AP, Baek J, Weisman MH, Kay J, et al. Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study. J Rheumatol. 2023;50:1287\u201395.","journal-title":"J Rheumatol"},{"key":"1191_CR53","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284\u201392.","journal-title":"Med Care"},{"key":"1191_CR54","unstructured":"American College of Obstetricians and Gynecologists (ACOG). Educational Resources for Providers, Patients, and Families. https:\/\/www.acog.org\/programs\/perinatal-mental-health\/educational-resources-for-providers-patients-and-families. Accessed 20 Mar 2025"},{"key":"1191_CR55","unstructured":"Health Resources and Services Administration (HRSA) National Maternal Mental Health Hotline. https:\/\/mchb.hrsa.gov\/programs-impact\/national-maternal-mental-health-hotline. Accessed\u00a07 Apr 2025"},{"key":"1191_CR56","unstructured":"Postpartum Support International. https:\/\/postpartum.net\/. Accessed\u00a024 Apr 2025"},{"key":"1191_CR57","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25045","volume":"75","author":"AR Bass","year":"2023","unstructured":"Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023;75:449\u201364.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1191_CR58","doi-asserted-by":"crossref","unstructured":"Flatman L, Bernatsky S, Malham\u00e9 I, St-Pierre Y, Basso O, B\u00e9rard A, Vinet E. Rotavirus vaccine in offspring exposed to tumour necrosis factor inhibitors during the third trimester does not increase diarrhea-associated healthcare events [abstract]. Arthritis Rheumatol. 2024;76 (suppl 9). https:\/\/acrabstracts.org\/abstract\/rotavirus-vaccine-in-offspring-exposed-to-tumour-necrosis-factorinhibitors-during-the-third-trimester-does-not-increase-diarrhea-associated-healthcare-events\/. Accessed 21 May 2025.","DOI":"10.1136\/annrheumdis-2024-eular.432"},{"key":"1191_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","volume":"16","author":"DB Beaulieu","year":"2018","unstructured":"Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines. Clin Gastroenterol Hepatol. 2018;16:99\u2013105.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1191_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/ibd\/izab033","volume":"28","author":"H Chiarella-Redfern","year":"2022","unstructured":"Chiarella-Redfern H, Lee S, Jubran B, Sharifi N, Panaccione R, Constantinescu C, et al. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants. Inflamm Bowel Dis. 2022;28:79\u201386.","journal-title":"Inflamm Bowel Dis"},{"key":"1191_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5217\/ir.2018.00071","volume":"17","author":"KE Lee","year":"2019","unstructured":"Lee KE, Jung SA, Park SH, Moon CM, Shim SY, Kim ES, Cho SJ, Kim SE, Cho KB, Yang SK. Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children\u2019s immunity. Intest Res. 2019;17:237\u201343.","journal-title":"Intest Res"},{"key":"1191_CR62","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1136\/annrheumdis-2014-205383","volume":"74","author":"J Brouwer","year":"2015","unstructured":"Brouwer J, Hazes JM, Laven JS, Dolhain RJ. Fertility in women with rheumatoid arthritis: influence of disease activity and medication. Ann Rheum Dis. 2015;74:1836\u201341.","journal-title":"Ann Rheum Dis"},{"key":"1191_CR63","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1089\/jwh.2020.8431","volume":"30","author":"SF Chen","year":"2021","unstructured":"Chen SF, Yang YC, Hsu CY, Shen YC. Risk of Rheumatoid Arthritis in Patients with Endometriosis: A Nationwide Population-Based Cohort Study. J Womens Health (Larchmt). 2021;30:1160\u20134.","journal-title":"J Womens Health (Larchmt)"},{"key":"1191_CR64","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1159\/000520133","volume":"183","author":"XH Zhang","year":"2022","unstructured":"Zhang XH, Zhang YA, Chen X, Qiao PY, Zhang LY. Assessment of the Ovarian Reserve by Serum Anti-M\u00fcllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2022;183:462\u20139.","journal-title":"Int Arch Allergy Immunol"},{"key":"1191_CR65","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.fertnstert.2021.07.1198","volume":"116","author":"BM N\u00f8rg\u00e5rd","year":"2021","unstructured":"N\u00f8rg\u00e5rd BM, Wod M, Larsen MD, Friedman S, J\u00f8lving LR, Fedder J. The impact of medical therapies and factors related to treatment procedures in women with rheumatoid arthritis and inflammatory bowel disease receiving assisted reproduction: a nationwide cohort study. Fertil Steril. 2021;116:1492\u2013500.","journal-title":"Fertil Steril"},{"key":"1191_CR66","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/acr.23724","volume":"71","author":"M Birru Talabi","year":"2019","unstructured":"Birru Talabi M, Clowse MEB, Blalock SJ, Moreland L, Siripong N, Borrero S. Contraception Use Among Reproductive-Age Women With Rheumatic Diseases. Arthritis Care Res (Hoboken). 2019;71:1132\u201340.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1191_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.contraception.2020.11.001","volume":"103","author":"OM Stransky","year":"2021","unstructured":"Stransky OM, Wolgemuth T, Kazmerski T, Chodoff A, Borrero S, Birru TM. Contraception decision-making and care among reproductive-aged women with autoimmune diseases. Contraception. 2021;103:86\u201391.","journal-title":"Contraception"},{"key":"1191_CR68","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jamainternmed.2024.3586","volume":"184","author":"CC Harper","year":"2024","unstructured":"Harper CC, Brown K, Arora KS. Contraceptive Access in the US Post-Dobbs. JAMA Intern Med. 2024;184:1279\u201380.","journal-title":"JAMA Intern Med"},{"key":"1191_CR69","doi-asserted-by":"publisher","first-page":"e1003110","DOI":"10.1371\/journal.pmed.1003110","volume":"17","author":"CS Todd","year":"2020","unstructured":"Todd CS, Jones HE, Langwenya N, Hoover DR, Chen PL, Petro G, et al. Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial. PLoS Med. 2020;17:e1003110.","journal-title":"PLoS Med"},{"key":"1191_CR70","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.contraception.2016.06.011","volume":"94","author":"NK Tepper","year":"2016","unstructured":"Tepper NK, Curtis KM, Nanda K, Jamieson DJ. Safety of intrauterine devices among women with HIV: a systematic review. Contraception. 2016;94:713\u201324.","journal-title":"Contraception"},{"key":"1191_CR71","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/17512433.2022.2100347","volume":"15","author":"S Su","year":"2022","unstructured":"Su S, Vincent KL. Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy. Expert Rev Clin Pharmacol. 2022;15:659\u201370.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1191_CR72","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.contraception.2016.05.002","volume":"94","author":"TC Jatlaoui","year":"2016","unstructured":"Jatlaoui TC, Curtis KM. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Contraception. 2016;94:605\u201311.","journal-title":"Contraception"},{"key":"1191_CR73","unstructured":"Center for Disease Control. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. https:\/\/www.cdc.gov\/contraception\/hcp\/usmec\/index.html. Accessed\u00a03 Jan 2025"},{"key":"1191_CR74","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1017\/S1431927620024289","volume":"26","author":"AC Swanepoel","year":"2020","unstructured":"Swanepoel AC, Bester J, de Lange-Loots Z. Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users. Microsc Microanal. 2020;26:1007\u201313.","journal-title":"Microsc Microanal"},{"key":"1191_CR75","doi-asserted-by":"publisher","first-page":"678","DOI":"10.23736\/S2724-606X.20.04688-2","volume":"73","author":"ML Rocca","year":"2021","unstructured":"Rocca ML, Palumbo AR, Bitonti G, Brisinda C, Di Carlo C. Bone health and hormonal contraception. Minerva Obstet Gynecol. 2021;73:678\u201396.","journal-title":"Minerva Obstet Gynecol"},{"key":"1191_CR76","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/art.41249","volume":"72","author":"MD Lockshin","year":"2020","unstructured":"Lockshin MD, Guerra M, Salmon JE. Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases. Arthritis Rheumatol. 2020;72:1325\u20139.","journal-title":"Arthritis Rheumatol"},{"key":"1191_CR77","unstructured":"AbortionFinder. https:\/\/www.abortionfinder.org\/. Accessed\u00a04 Mar 2025"},{"key":"1191_CR78","unstructured":"PlanC. https:\/\/www.plancpills.org\/. Accessed\u00a011 Feb 2025"},{"key":"1191_CR79","unstructured":"INeedAnA. https:\/\/www.ineedana.com\/. Accessed\u00a018 Apr 2025"},{"key":"1191_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00393-020-00890-4","volume":"80","author":"RB Saad","year":"2021","unstructured":"Saad RB, Fazaa A, Rouached L, Miladi S, Ouenniche K, Souabni L, et al. Sexual dysfunction and its determinants in women with rheumatoid arthritis. Z Rheumatol. 2021;80:373\u20138.","journal-title":"Z Rheumatol"},{"key":"1191_CR81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00296-024-05555-y","volume":"44","author":"LT Bay","year":"2024","unstructured":"Bay LT, Nielsen DS, Flurey C, Giraldi A, M\u00f6ller S, Graugaard C, et al. Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage. Rheumatol Int. 2024;44:919\u201331.","journal-title":"Rheumatol Int"},{"key":"1191_CR82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s41927-024-00441-3","volume":"8","author":"LF Perez-Garcia","year":"2024","unstructured":"Perez-Garcia LF, R\u00f6der E, Pastoor H, Lozada-Navarro AC, Colunga-Pedraza I, Vargas-Aguirre T, et al. Discussing male sexual and reproductive health in the rheumatology outpatient clinic: a Q-methodology study. BMC Rheumatol. 2024;8:67.","journal-title":"BMC Rheumatol"},{"key":"1191_CR83","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3899\/jrheum.210785","volume":"49","author":"O Stransky","year":"2022","unstructured":"Stransky O, Hunt N, Richards JS, Talabi MB. Exploring Family Planning, Parenting, and Sexual and Reproductive Health Care Experiences of Men With Rheumatic Diseases. J Rheumatol. 2022;49:251\u20135.","journal-title":"J Rheumatol"},{"key":"1191_CR84","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s10067-020-05551-0","volume":"40","author":"Y El Miedany","year":"2021","unstructured":"El Miedany Y, Palmer D. Rheumatology-led pregnancy clinic: men perspective. Clin Rheumatol. 2021;40:3067\u201377.","journal-title":"Clin Rheumatol"},{"key":"1191_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.09.004","volume":"64","author":"BL Bermas","year":"2020","unstructured":"Bermas BL. Paternal safety of anti-rheumatic medications. Best Pract Res Clin Obset Gynaecol. 2020;64:77\u201384.","journal-title":"Best Pract Res Clin Obset Gynaecol"},{"key":"1191_CR86","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/ibd\/izab205","volume":"28","author":"A Grosen","year":"2022","unstructured":"Grosen A, Bellaguarda E, Nersting J, Hvas CL, Liljeqvist-Soltic I, Stein A, et al. Low-dose Methotrexate Therapy Does Not Affect Semen Parameters and Sperm DNA. Inflamm Bowel Dis. 2022;28:1012\u20138.","journal-title":"Inflamm Bowel Dis"},{"key":"1191_CR87","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.semarthrit.2015.06.016","volume":"45","author":"M Kumar","year":"2015","unstructured":"Kumar M, Ray L, Vemuri S, Simon TA. Pregnancy outcomes following exposure to abatacept during pregnancy. Semin Arthritis Rheum. 2015;45:351\u20136.","journal-title":"Semin Arthritis Rheum"}],"updated-by":[{"DOI":"10.1007\/s11926-025-01196-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000}}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01191-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01191-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:04:24Z","timestamp":1770750264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01191-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01191-y","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"15 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The author\u2019s name \"Mehret\" was incorrectly written as \"Mahret\". Full information regarding the corrections made can be found in the erratum\/correction for this article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11926-025-01196-7","URL":"https:\/\/doi.org\/10.1007\/s11926-025-01196-7","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"26"}}